Published in Emerg Infect Dis on November 01, 2015
Molecular surveillance of nasopharyngeal carriage of Streptococcus pneumoniae in children vaccinated with conjugated polysaccharide pneumococcal vaccines. Sci Rep (2016) 0.83
Interim results of an ecological experiment - Conjugate vaccination against the pneumococcus and serotype replacement. Hum Vaccin Immunother (2016) 0.83
Other age groups than children need to be considered as carriers of Streptococcal pneumoniae serotypes. Hum Vaccin Immunother (2016) 0.82
Response to Wu et al. - Cost-effectiveness analysis of infant pneumococcal vaccination in Malaysia and Hong Kong. Hum Vaccin Immunother (2016) 0.77
Molecular surveillance on Streptococcus pneumoniae carriage in non-elderly adults; little evidence for pneumococcal circulation independent from the reservoir in children. Sci Rep (2016) 0.75
Sequencing of the variable region of rpsB to discriminate between Streptococcus pneumoniae and other streptococcal species. Open Biol (2017) 0.75
Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany. Eur J Health Econ (2016) 0.75
Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study. Lancet Respir Med (2014) 2.88
Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites. PLoS Med (2013) 2.54
Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands. Emerg Infect Dis (2010) 2.48
Influenza- and respiratory syncytial virus-associated mortality and hospitalisations. Eur Respir J (2007) 2.27
Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine. Pediatr Infect Dis J (2009) 1.80
Invasive pneumococcal disease and 7-valent pneumococcal conjugate vaccine, the Netherlands. Emerg Infect Dis (2012) 1.50
Long-term effects of pneumococcal conjugate vaccine on nasopharyngeal carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis. PLoS One (2012) 1.43
Effects of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D-conjugate vaccine on nasopharyngeal bacterial colonization in young children: a randomized controlled trial. Clin Infect Dis (2012) 1.32
The impact of 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease: a literature review. Adv Ther (2013) 1.19
Invasive pneumococcal diseases in birth cohorts vaccinated with PCV-7 and/or PHiD-CV in the province of Quebec, Canada. Vaccine (2012) 1.03
Immunogenicity, safety, and reactogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine and DTPa-IPV-Hib when coadministered as a 3-dose primary vaccination schedule in The Netherlands: a randomized controlled trial. Pediatr Infect Dis J (2011) 1.01
Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med (2015) 5.86
Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis (2010) 2.50
Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands. Emerg Infect Dis (2010) 2.48
CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia. J Allergy Clin Immunol (2011) 2.10
Effectiveness of trimethoprim/sulfamethoxazole for children with chronic active otitis media: a randomized, placebo-controlled trial. Pediatrics (2007) 2.06
Two-year assessment of effect of topical corticosteroids on bone mineral density in adults with moderate to severe atopic dermatitis. J Am Acad Dermatol (2012) 1.97
Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage. J Infect Dis (2013) 1.91
The impact of breastfeeding on nasopharyngeal microbial communities in infants. Am J Respir Crit Care Med (2014) 1.78
Deep sequencing analyses of low density microbial communities: working at the boundary of accurate microbiota detection. PLoS One (2012) 1.76
Viral and bacterial interactions in the upper respiratory tract. PLoS Pathog (2013) 1.74
Chronic suppurative otitis media: a review. Int J Pediatr Otorhinolaryngol (2005) 1.70
Pneumococcal conjugate vaccines for preventing otitis media. Cochrane Database Syst Rev (2014) 1.70
Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands. Pediatr Infect Dis J (2008) 1.69
Otitis media and its consequences: beyond the earache. Lancet Infect Dis (2010) 1.68
Multi locus sequence typing of Chlamydiales: clonal groupings within the obligate intracellular bacteria Chlamydia trachomatis. BMC Microbiol (2008) 1.65
Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome. Clin Infect Dis (2009) 1.65
Associations between pathogens in the upper respiratory tract of young children: interplay between viruses and bacteria. PLoS One (2012) 1.63
Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis. PLoS One (2010) 1.61
Effect of pneumococcal vaccination on quality of life in children with recurrent acute otitis media: a randomized, controlled trial. Pediatrics (2005) 1.59
Detection of pulmonary complications in common variable immunodeficiency. Pediatr Allergy Immunol (2009) 1.56
Invasive pneumococcal disease and 7-valent pneumococcal conjugate vaccine, the Netherlands. Emerg Infect Dis (2012) 1.50
Carriage of Streptococcus pneumoniae 3 years after start of vaccination program, the Netherlands. Emerg Infect Dis (2011) 1.49
Early respiratory microbiota composition determines bacterial succession patterns and respiratory health in children. Am J Respir Crit Care Med (2014) 1.49
Multiple-locus variable-number tandem repeat analysis of Neisseria meningitidis yields groupings similar to those obtained by multilocus sequence typing. J Clin Microbiol (2006) 1.48
Adjunctive dexamethasone in adults with meningococcal meningitis. Neurology (2012) 1.48
Increased attack rate of meningococcal disease in children with a pregnant mother. Pediatrics (2005) 1.46
Long-term effects of pneumococcal conjugate vaccine on nasopharyngeal carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis. PLoS One (2012) 1.43
Interpretation of subgroup analyses in randomized trials: heterogeneity versus secondary interventions. Ann Intern Med (2011) 1.38
Genetic polymorphisms in immunoresponse genes TNFA, IL6, IL10, and TLR4 are associated with recurrent acute otitis media. Pediatrics (2007) 1.37
Multi locus sequence typing of Chlamydia reveals an association between Chlamydia psittaci genotypes and host species. PLoS One (2010) 1.37
Increase in genetic diversity of Haemophilus influenzae serotype b (Hib) strains after introduction of Hib vaccination in The Netherlands. J Clin Microbiol (2005) 1.33
Effects of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D-conjugate vaccine on nasopharyngeal bacterial colonization in young children: a randomized controlled trial. Clin Infect Dis (2012) 1.32
[High vaccination coverage of the National Immunization Programme in the Netherlands]. Ned Tijdschr Geneeskd (2009) 1.30
Remarks on antagonism. Am J Epidemiol (2011) 1.26
Effect of seven-valent pneumococcal conjugate vaccine on Staphylococcus aureus colonisation in a randomised controlled trial. PLoS One (2011) 1.25
Pertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants? Vaccine (2013) 1.24
Return of Haemophilus influenzae type b infections. Lancet (2003) 1.24
Pathogen adaptation under imperfect vaccination: implications for pertussis. Proc Biol Sci (2005) 1.24
Characterization of diverse subvariants of the meningococcal factor H (fH) binding protein for their ability to bind fH, to mediate serum resistance, and to induce bactericidal antibodies. Infect Immun (2010) 1.24
Complement component 5 contributes to poor disease outcome in humans and mice with pneumococcal meningitis. J Clin Invest (2011) 1.24
Pneumococcal conjugate vaccination and nasopharyngeal acquisition of pneumococcal serotype 19A strains. JAMA (2010) 1.21
Compositional discordance between prokaryotic plasmids and host chromosomes. BMC Genomics (2006) 1.20
Immunity against Neisseria meningitidis serogroup C in the Dutch population before and after introduction of the meningococcal c conjugate vaccine. PLoS One (2010) 1.15
Of microbe and man: determinants of Helicobacter pylori-related diseases. FEMS Microbiol Rev (2006) 1.14
Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands. Pediatr Infect Dis J (2006) 1.14
Population structure of invasive Streptococcus pneumoniae in The Netherlands in the pre-vaccination era assessed by MLVA and capsular sequence typing. PLoS One (2011) 1.14
Impact of treatment reduction for childhood acute lymphoblastic leukemia on serum immunoglobulins and antibodies against vaccine-preventable diseases. Pediatr Blood Cancer (2011) 1.12
Sequence diversity within the capsular genes of Streptococcus pneumoniae serogroup 6 and 19. PLoS One (2011) 1.12
Gross deletions involving IGHM, BTK, or Artemis: a model for genomic lesions mediated by transposable elements. Am J Hum Genet (2008) 1.12
Room for improvement in conducting and reporting non-inferiority randomized controlled trials on drugs: a systematic review. PLoS One (2010) 1.11
Listeria monocytogenes sequence type 6 and increased rate of unfavorable outcome in meningitis: epidemiologic cohort study. Clin Infect Dis (2013) 1.11
Soluble triggering receptor expressed on myeloid cells 1: a biomarker for bacterial meningitis. Intensive Care Med (2006) 1.11
Mumps outbreak in a highly vaccinated student population, The Netherlands, 2004. Vaccine (2010) 1.10
Differences in the population structure of invasive Streptococcus suis strains isolated from pigs and from humans in The Netherlands. PLoS One (2012) 1.10
Central role of complement in passive protection by human IgG1 and IgG2 anti-pneumococcal antibodies in mice. J Immunol (2003) 1.10
A Helicobacter pylori TolC efflux pump confers resistance to metronidazole. Antimicrob Agents Chemother (2005) 1.10
Using pneumococcal carriage data to monitor postvaccination changes in invasive disease. Am J Epidemiol (2013) 1.09
Seroprevalence of seven high-risk HPV types in The Netherlands. Vaccine (2012) 1.09
Seven-valent pneumococcal conjugate vaccine and nasopharyngeal microbiota in healthy children. Emerg Infect Dis (2014) 1.08
Naturally occurring lipid A mutants in neisseria meningitidis from patients with invasive meningococcal disease are associated with reduced coagulopathy. PLoS Pathog (2009) 1.08
Nontypeable Haemophilus influenzae invasive disease in The Netherlands: a retrospective surveillance study 2001-2008. Clin Infect Dis (2011) 1.07
Clinical features, outcome, and meningococcal genotype in 258 adults with meningococcal meningitis: a prospective cohort study. Medicine (Baltimore) (2008) 1.06
Cost-effectiveness of vaccination against meningococcal B among Dutch infants: Crucial impact of changes in incidence. Hum Vaccin Immunother (2013) 1.04
Effect of 7-valent pneumococcal conjugate vaccine on nasopharyngeal carriage with Haemophilus influenzae and Moraxella catarrhalis in a randomized controlled trial. Vaccine (2011) 1.04
Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome. Biol Blood Marrow Transplant (2008) 1.03
IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content. Vaccine (2009) 1.02
Immunogenicity, safety, and reactogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine and DTPa-IPV-Hib when coadministered as a 3-dose primary vaccination schedule in The Netherlands: a randomized controlled trial. Pediatr Infect Dis J (2011) 1.01
Is it cost-effective to introduce rotavirus vaccination in the Dutch national immunization program? Vaccine (2010) 1.01
Full genome sequences of all nine Chlamydia psittaci genotype reference strains. J Bacteriol (2012) 1.01
Invasive pneumococcal disease in the Netherlands: Syndromes, outcome and potential vaccine benefits. Vaccine (2009) 1.01
Cerebral infarction in adults with bacterial meningitis. Neurocrit Care (2012) 1.00
Involvement of glycosaminoglycans in the attachment of pneumococci to nasopharyngeal epithelial cells. Microbes Infect (2005) 1.00
Why parents refuse childhood vaccination: a qualitative study using online focus groups. BMC Public Health (2013) 1.00
Assessing the introduction of universal human papillomavirus vaccination for preadolescent girls in The Netherlands. Vaccine (2007) 1.00
Superiority of trans-oral over trans-nasal sampling in detecting Streptococcus pneumoniae colonization in adults. PLoS One (2013) 0.99
Hydrocephalus in adults with community-acquired bacterial meningitis. Neurology (2010) 0.99
Does physical activity modify the risk of obesity for type 2 diabetes: a review of epidemiological data. Eur J Epidemiol (2009) 0.99
Pneumococcal conjugate vaccines for preventing otitis media. Cochrane Database Syst Rev (2009) 0.99
HPV16/18 vaccination to prevent cervical cancer in The Netherlands: model-based cost-effectiveness. Int J Cancer (2009) 0.99
Changes in the composition of the pneumococcal population and in IPD incidence in The Netherlands after the implementation of the 7-valent pneumococcal conjugate vaccine. Vaccine (2012) 0.99
Decline in influenza-associated mortality among Dutch elderly following the introduction of a nationwide vaccination program. Vaccine (2008) 0.98
Frequent attendance of primary care out-of-hours services in the Netherlands: characteristics of patients and presented morbidity. Fam Pract (2009) 0.97